Drug prices continue to go up
Medicare
Category
FDA-Lead Research Effort to Compare Clinical Trial Results vs. Medicare Beneficiaries Receiving Idelalisib
A research team, including the Food and Drug Administration (FDA) Stanford and a boutique data analysis firm called Acumen, set up a study comparing outcomes between relapsed follicular lymphoma and relapsed chronic lymphocytic leukemia patients treated with...
Humana Investment in Holistic Value-Based Care Improves Health Outcomes
Large payer Humana reports that chronic disease represents a significant challenge for older Americans. They have found that using a holistic approach by leveraging value-based reimbursement models to improve health outcomes and quality measures for Medicare Advantage...